CCL5 and steatosis: Notably, plasma chemokine concentrations showed divergent dynamics after six months of follow-up, with RANTES exhibiting the strongest increase in patients with decreasing hepatic fat content and MIP1b in those with progressive steatosis (Figure 4G).